Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nematode glutamate-gated chloride channel (GluCl) is a member of the Cys-loop family of ligand-gated ion channels, found exclusively in invertebrates such as nematodes and arthropods [1]. These channels mediate fast inhibitory neurotransmission by allowing the influx of chloride ions upon activation by L-glutamate, leading to membrane hyperpolarization [2]. GluCls play critical roles in regulating nematode locomotion, feeding through pharyngeal pumping, and sensory input processing [3]. They are the primary molecular targets for the avermectin and milbemycin classes of anthelmintic drugs, most notably ivermectin [4]. By binding to the transmembrane domain of the channel, these drugs act as potent agonists or allosteric activators, causing prolonged channel opening [1, 2]. This persistent activation results in flaccid paralysis and eventual death of the parasite [1]. Because GluCls are absent in vertebrates, they provide a high margin of therapeutic safety for the host [4]. However, at high concentrations, these drugs can potentially interact with vertebrate GABA or glycine receptors [2]. Resistance to these drugs is an emerging concern, often linked to mutations in the GluCl subunits [1]. Understanding the structure and function of GluCl remains vital for developing new antiparasitic agents [2].
Drugs targeting this channel act as potent allosteric agonists or activators that bind to the transmembrane domain, stabilizing the open state of the channel and causing a persistent influx of chloride ions, which leads to hyperpolarization and flaccid paralysis of the parasite [1, 2, 4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nematode glutamate-gated chloride channel (GluCl) (GluCl).